When is the Best Time for the Second Antiplatelet Agent in Non-St Elevation Acute Coronary Syndrome?

Dual antiplatelet therapy is a well-established treatment in patients with non-ST elevation acute coronary syndrome (NSTE-ACS), with class I of recommendation (level of evidence A) in current national and international guidelines. Nonetheless, these guidelines are not precise or consensual regarding...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Pedro Gabriel Melo de Barros e, Ribeiro, Henrique Barbosa, Baruzzi, Antônio Claudio do Amaral, da Silva, Expedito Eustáquio Ribeiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Cardiologia - SBC 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811279/
https://www.ncbi.nlm.nih.gov/pubmed/27027367
http://dx.doi.org/10.5935/abc.20160042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811279/
https://www.ncbi.nlm.nih.gov/pubmed/27027367
http://dx.doi.org/10.5935/abc.20160042

Ejemplares similares